Invention Grant
- Patent Title: Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
-
Application No.: US15168466Application Date: 2016-05-31
-
Publication No.: US09662323B2Publication Date: 2017-05-30
- Inventor: Laura Carzaniga , Fabio Rancati , Andrea Rizzi , Ian Linney , Wolfgang Schmidt , Michael Barnes , Chris Knight
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP15170033 20150601
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; C07D453/02 ; A61K9/00 ; A61M15/00 ; A61M16/14
Abstract:
Compounds of formula I, defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating diseases of the respiratory tract.
Public/Granted literature
- US20160346271A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Public/Granted day:2016-12-01
Information query
IPC分类:
